Home › Funds › Woodline Partners LP › EW

Woodline Partners LP position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Woodline Partners LP reported holding 1,560,062 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q2 2026 13F filing — a position valued at US$141.1M, representing 0.44% of its reported portfolio and ranking #39 among its reported holdings. Woodline Partners LP has disclosed EW holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)1.56M sh
Reported value held$141.12M
Portfolio Weight0.44%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Woodline Partners LP's EW position evolved

Woodline Partners LP first disclosed a stake in EW in Q4 2023 at 301,712 shares (US$23.0M). The position peaked in Q1 2026 at 1,768,176 shares, worth US$141.6M. Across 11 filings, Woodline Partners LP increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,560,062 shares valued at US$141.1M — a reduction of -208,114 shares quarter over quarter.. Notable position changes include a 97% trim in Q4 2024 (shares fell 2% over the following quarter), a 7805% increase in Q1 2025 (shares rose 8% over the following quarter), a 91% increase in Q4 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 301.71K $23.01M New
Q1 2024 481.93K $46.05M Add
Q2 2024 266.08K $24.58M Reduce
Q3 2024 353.24K $23.31M Add
Q4 2024 10.44K $772.95K Reduce
Q1 2025 825.36K $59.82M Add
Q2 2025 1.02M $79.77M Add
Q3 2025 559.54K $43.52M Reduce
Q4 2025 1.07M $91.27M Add
Q1 2026 1.77M $141.60M Add
Q2 2026 1.56M $141.12M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Woodline Partners LP held EW?

Woodline Partners LP has disclosed EW holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Woodline Partners LP's current position in EW?

As of Q2 2026, Woodline Partners LP holds 1.56M shares of EW (EDWARDS LIFESCIENCES CORP), valued at $141.12M, representing 0.44% of its reported portfolio and ranking #39.

Has Woodline Partners LP been buying or selling EW?

In the latest 13F filing (Q2 2026), Woodline Partners LP reduced its position in EW. The position peaked in Q1 2026 at 1.77M shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.